These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25447717)

  • 1. Sepsis caused by New Delhi metallo-β-lactamase (blaNDM-1) and qnrD-producing Morganella morganii, treated successfully with fosfomycin and meropenem: case report and literature review.
    Seija V; Medina Presentado JC; Bado I; Papa Ezdra R; Batista N; Gutierrez C; Guirado M; Vidal M; Nin M; Vignoli R
    Int J Infect Dis; 2015 Jan; 30():20-6. PubMed ID: 25447717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly multidrug-resistant
    Shrestha S; Tada T; Sherchan JB; Uchida H; Hishinuma T; Oshiro S; Morioka S; Kattel H; Kirikae T; Sherchand JB
    J Med Microbiol; 2020 Apr; 69(4):572-575. PubMed ID: 32100711
    [No Abstract]   [Full Text] [Related]  

  • 3. "Double carbapenem" and oral fosfomycin for the treatment of complicated urinary tract infections caused by bla
    Rosa R; Rudin SD; Rojas LJ; Hujer AM; Perez-Cardona A; Perez F; Bonomo RA; Martinez O; Abbo LM; Camargo JF
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29064133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morganella morganii, a non-negligent opportunistic pathogen.
    Liu H; Zhu J; Hu Q; Rao X
    Int J Infect Dis; 2016 Sep; 50():10-7. PubMed ID: 27421818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular investigation of extended-spectrum beta-lactamase genes and potential drug resistance in clinical isolates of Morganella morganii.
    Al-Muhanna AS; Al-Muhanna S; Alzuhairi MA
    Ann Saudi Med; 2016; 36(3):223-8. PubMed ID: 27236395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of KPC-2 and qnrS1 in clinical isolates of Morganella morganii from China.
    Cai JC; Yang W; Hu YY; Zhang R; Zhou HW; Chen GX
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):207-9. PubMed ID: 22542894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant
    Amladi AU; Abirami B; Devi SM; Sudarsanam TD; Kandasamy S; Kekre N; Veeraraghavan B; Sahni RD
    Indian J Med Res; 2019 Feb; 149(2):185-191. PubMed ID: 31219082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic analysis of two drug-resistant clinical Morganella morganii strains isolated from UTI patients in Pretoria, South Africa.
    Mbelle N; Osei Sekyere J; Feldman C; Maningi NE; Modipane L; Essack SY
    Lett Appl Microbiol; 2020 Jan; 70(1):21-28. PubMed ID: 31630429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First characterisation of plasmid-mediated quinolone resistance-qnrS1 co-expressed bla CTX-M-15 and bla DHA-1 genes in clinical strain of Morganella morganii recovered from a Tunisian Intensive Care Unit.
    Mahrouki S; Bourouis A; Chihi H; Ouertani R; Ferjani M; Moussa MB; Barguellil F; Belhadj O
    Indian J Med Microbiol; 2012; 30(4):437-41. PubMed ID: 23183469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Delhi Metallo-β-Lactamase 1(NDM-1), the Dominant Carbapenemase Detected in Carbapenem-Resistant Enterobacter cloacae from Henan Province, China.
    Liu C; Qin S; Xu H; Xu L; Zhao D; Liu X; Lang S; Feng X; Liu HM
    PLoS One; 2015; 10(8):e0135044. PubMed ID: 26263489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
    Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
    J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt.
    Khalifa HO; Soliman AM; Ahmed AM; Shimamoto T; Hara T; Ikeda M; Kuroo Y; Kayama S; Sugai M; Shimamoto T
    Microb Drug Resist; 2017 Oct; 23(7):838-844. PubMed ID: 28191865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and molecular characterisation of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug-resistant Enterobacteriaceae from India.
    Rahman M; Shukla SK; Prasad KN; Ovejero CM; Pati BK; Tripathi A; Singh A; Srivastava AK; Gonzalez-Zorn B
    Int J Antimicrob Agents; 2014 Jul; 44(1):30-7. PubMed ID: 24831713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.
    Sully EK; Geller BL; Li L; Moody CM; Bailey SM; Moore AL; Wong M; Nordmann P; Daly SM; Sturge CR; Greenberg DE
    J Antimicrob Chemother; 2017 Mar; 72(3):782-790. PubMed ID: 27999041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
    Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
    Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.
    Chibabhai V; Nana T; Bosman N; Thomas T; Lowman W
    Infection; 2018 Feb; 46(1):1-13. PubMed ID: 28916900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1.
    Datta S; Roy S; Chatterjee S; Saha A; Sen B; Pal T; Som T; Basu S
    PLoS One; 2014; 9(11):e112101. PubMed ID: 25406074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of Bacteremia Due to NDM-1-Producing
    Hobson CA; Bonacorsi S; Fahd M; Baruchel A; Cointe A; Poey N; Jacquier H; Doit C; Monjault A; Tenaillon O; Birgy A
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530600
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
    Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
    Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.